SCHEMBL9970782

SCHEMBL9970782

CCN(CC)C(=O)c1ccc[nH]c1=S

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.56
GAA P10253 4/20 0.56
KDM4E B2RXH2 2/20 0.56
KEAP1 Q14145 1/20 0.44
TP53 P04637 1/20 0.43
ALDH1A1 P00352 4/20 0.42
TSHR P16473 2/20 0.42
HTT P42858 1/20 0.42
APOBEC3G Q9HC16 1/20 0.42
MAPK1 P28482 1/20 0.42
HPGD P15428 3/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
ADRA1D P25100 1/20 0.39
ADRA1A P35348 1/20 0.39
ADRA1B P35368 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
GUSB P08236 1/20 0.39
HSP90AA1 P07900 2/20 0.39
HSP90AB1 P08238 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9937284 0.90 MAPT (0.49) MAPTGAAKDM4EKEAP1TP53
SCHEMBL9937465 0.90 MAPT (0.49) MAPTGAAKDM4EKEAP1TP53
SCHEMBL21361326 0.84 GAA (0.53) MAPTGAAKDM4ETP53ALDH1A1
SCHEMBL9936056 0.82 GAA (0.54) MAPTGAAKDM4ETP53ALDH1A1
SCHEMBL9970786 0.81 GAA (0.61) MAPTGAAKDM4EKEAP1ALDH1A1
SCHEMBL21812510 0.78 GAA (0.50) MAPTGAAKDM4ETP53ALDH1A1
SCHEMBL19017275 0.76 GAA (0.51) MAPTGAAKDM4ETP53ALDH1A1
SCHEMBL18985307 0.76 GAA (0.56) MAPTGAAKDM4EALDH1A1HTT
SCHEMBL29822323 0.76 TP53 (0.69) MAPTKEAP1TP53ALDH1A1TSHR
SCHEMBL610480 0.76 TP53 (0.69) MAPTKEAP1TP53ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210401709-A1 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS L'ORÉAL (FR) 2021-12-30 US disclosed
US-11052028-B2 Process for depigmenting keratin materials using thiopyridinone compounds L'OREAL (FR) 2021-07-06 US disclosed
EP-2651897-B1 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS OREAL (FR) 2020-04-01 EP disclosed
US-20160045420-A1 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS L'OREAL (FR) 2016-02-18 US disclosed
US-20160045420-A1 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS L'OREAL (FR) 2016-02-18 US disclosed
US-9138392-B2 Process for depigmenting keratin materials using thiopyridinone compounds L'OREAL (FR) 2015-09-22 US disclosed
US-9138392-B2 Process for depigmenting keratin materials using thiopyridinone compounds L'OREAL (FR) 2015-09-22 US disclosed
WO-2012080075-A1 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS L'OREAL (FR) 2012-06-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160045420-A1 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS CBR3, RTN3, HRH4 MAPT 1622/4885GAA 4768/4885KDM4E 588/4885
US-20210401709-A1 PROCESS FOR DEPIGMENTING KERATIN MATERIALS USING THIOPYRIDINONE COMPOUNDS CBR3, HRH4, RTN3 MAPT 1383/4885GAA 4751/4885KDM4E 425/4885
US-11052028-B2 Process for depigmenting keratin materials using thiopyridinone compounds KRT18, PKN1, PTMA MAPT 232/4885GAA 2542/4885KDM4E 126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.